In May 2010, a New York jury ordered Novartis to pay $250m in punitive damages to nearly 6,000 current and former female employees of its US pharmaceuticals division, in what plaintiffs’ lawyers claimed at the time was the largest gender discrimination case in the country.The jury decided the Swiss pharmaceuticals giant had discriminated against women in pay, promotion and pregnancy. The ruling provided less than ideal publicity for a multinational that, like its Swiss peers, prided itself on a multicultural environment and blindness to race, colour or creed.
See full Article, paid subscription required.
Posts
